Abstract
Type 2 Diabetes (T2D) poses a formidable global health challenge, with its escalating prevalence contributing significantly to increased morbidity, mortality, and healthcare costs. This chronic condition, characterized by insulin resistance and hyperglycemia, leads to a plethora of complications, intensifying its societal and economic impact. Exercise, as a fundamental element of T2D management, is universally recommended for its ability to improve glycemic control and mitigate cardiovascular risks. However, individual responses to exercise vary considerably among T2D patients, leading to inconsistencies in the effectiveness of generic exercise plans. This heterogeneity in response to different exercise interventions highlights the need for more personalized approaches, tailoring exercise plans to individual patient profiles to optimize therapeutic outcomes. Our study addresses this critical need through the development of the T2DFitTailor package, a novel R-based tool that customizes exercise recommendations for T2D patients. Utilizing a comprehensive analysis of individual parameters, T2DFitTailor accurately predicts the impact of specific exercise plans on the reduction of glycated hemoglobin (HbA1c) levels. This personalized approach to exercise prescription in T2D management is a significant step forward in optimizing treatment strategies. It allows for a more targeted, effective intervention, thereby improving patient outcomes and quality of life. T2DFitTailor, accessible at ‘https://cran.r-project.org/package=T2DFitTailor’, represents a notable contribution to T2D care, reflecting the ongoing shift towards more data-driven and personalized healthcare strategies. This tool provides a practical solution to meet the varied requirements of T2D patients, ensuring that exercise prescriptions are not only based on scientific evidence but also customized to suit individual health profiles and specific needs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
